Literature DB >> 17694360

Selective prostaglandin G/H synthase (PGHS)-2 inhibitors show greater inhibitory activities on human PGHS-2 than on murine PGHS-2 in intact cells.

J Berg1, H Fellier, A Bodenteich, T Christoph, R Towart.   

Abstract

Excess eicosanoid formation during inflammation has been attributed to the expression of the gene coding for the inducible isoform of prostaglandin G/H synthase (PGHS-2). Human and murine PGHS-2 proteins differ in 73 out of the 604 amino acids. When comparing the inhibitory effects of a panel of PGHS-inhibitors in a whole cell human and murine PGHS-2 assay carried out under identical conditions, classical NSAIDs with the exception of aspirin and tenoxicam showed similar inhibitory effects on both human and murine PGHS-2 enzymes. However, the PGHS-2 selective inhibitors nimesulide, flosulide and NS398 showed a much greater inhibition of human PGHS-2. We suggest that these differences could be due to the genetic differences of human and murine PGHS-2.

Entities:  

Year:  1997        PMID: 17694360     DOI: 10.1007/s10787-997-0020-y

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  28 in total

1.  In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.

Authors:  H Sano; T Hla; J A Maier; L J Crofford; J P Case; T Maciag; R L Wilder
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 2.  Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications.

Authors:  M Pairet; G Engelhardt
Journal:  Fundam Clin Pharmacol       Date:  1996       Impact factor: 2.748

3.  Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and Cox 2 inhibitors.

Authors:  C J Grossman; J Wiseman; F S Lucas; M A Trevethick; P J Birch
Journal:  Inflamm Res       Date:  1995-06       Impact factor: 4.575

4.  Nonlinear regression using spreadsheets.

Authors:  W P Bowen; J C Jerman
Journal:  Trends Pharmacol Sci       Date:  1995-12       Impact factor: 14.819

5.  TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

Authors:  D A Kujubu; B S Fletcher; B C Varnum; R W Lim; H R Herschman
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

6.  Human cyclooxygenase-2 cDNA.

Authors:  T Hla; K Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

7.  N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum.

Authors:  J C Otto; D L DeWitt; W L Smith
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

8.  Activity of nimesulide on constitutive and inducible cyclooxygenases.

Authors:  I A Tavares; P M Bishai; A Bennett
Journal:  Arzneimittelforschung       Date:  1995-10

9.  Cloning and expression of rat prostaglandin endoperoxide synthase (cyclooxygenase)-2 cDNA.

Authors:  B P Kennedy; C C Chan; S A Culp; W A Cromlish
Journal:  Biochem Biophys Res Commun       Date:  1993-12-15       Impact factor: 3.575

10.  NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

Authors:  N Futaki; S Takahashi; M Yokoyama; I Arai; S Higuchi; S Otomo
Journal:  Prostaglandins       Date:  1994-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.